Detalhe da pesquisa
1.
Time to Disability Milestones and Annualized Relapse Rates in NMOSD and MOGAD.
Ann Neurol
; 95(4): 720-732, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38086777
2.
Visual function resists early neurodegeneration in the visual system in primary progressive multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 94(11): 924-933, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37433662
3.
Cognition in patients with neuromyelitis optica spectrum disorders: A prospective multicentre study of 217 patients (CogniNMO-Study).
Mult Scler
; 29(7): 819-831, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36786424
4.
Brain grey matter perfusion in primary progressive multiple sclerosis: Mild decrease over years and regional associations with cognition and hand function.
Eur J Neurol
; 29(6): 1741-1752, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35167161
5.
Pain, depression, and quality of life in adults with MOG-antibody-associated disease.
Eur J Neurol
; 28(5): 1645-1658, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33423336
6.
"A second birthday"? Experiences of persons with multiple sclerosis treated with autologous hematopoietic stem cell transplantation-a qualitative interview study.
Front Neurol
; 15: 1384551, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38751886
7.
Benefits of aHSCT over alemtuzumab in patients with multiple sclerosis besides disability and relapses: Sustained improvement in cognition and quality of life.
Mult Scler Relat Disord
; 82: 105414, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38176284
8.
Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management.
J Neurol
; 271(1): 141-176, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37676297
9.
Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis.
J Neurol
; 270(7): 3341-3368, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37022481
10.
Autologous haematopoietic stem cell transplantation for multiple sclerosis: a position paper and registry outline.
Ther Adv Neurol Disord
; 16: 17562864231180730, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37780055
11.
Effects of the COVID-19 Pandemic on Patients With NMO Spectrum Disorders and MOG-Antibody-Associated Diseases: COPANMO(G)-Study.
Neurol Neuroimmunol Neuroinflamm
; 10(2)2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36693760
12.
Treating sarcoidosis-associated progressive multifocal leukoencephalopathy with infliximab.
Brain Commun
; 4(1): fcab292, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34993476
13.
Costs and Health-Related Quality of Life in Patients With NMO Spectrum Disorders and MOG-Antibody-Associated Disease: CHANCENMO Study.
Neurology
; 98(11): e1184-e1196, 2022 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35082170
14.
Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG-Associated Disease and Neuromyelitis Optica Spectrum Disorders.
Neurol Neuroimmunol Neuroinflamm
; 9(1)2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34785575
15.
aHSCT is superior to alemtuzumab in maintaining NEDA and improving cognition in multiple sclerosis.
Ann Clin Transl Neurol
; 8(6): 1269-1278, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33949790
16.
Pain, Depression, and Quality of Life in Neuromyelitis Optica Spectrum Disorder: A Cross-Sectional Study of 166 AQP4 Antibody-Seropositive Patients.
Neurol Neuroimmunol Neuroinflamm
; 8(3)2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34108267
17.
Intravenous Immunoglobulin (IVIg) Induce a Protective Phenotype in Microglia Preventing Neuronal Cell Death in Ischaemic Stroke.
Neuromolecular Med
; 22(1): 121-132, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31559534
18.
Assessing the effect of an evidence-based patient online educational tool for people with multiple sclerosis called UMIMS-understanding magnetic resonance imaging in multiple sclerosis: study protocol for a double-blind, randomized controlled trial.
Trials
; 21(1): 1008, 2020 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33298133
19.
Relapse rates and long-term outcome in primary angiitis of the central nervous system.
J Neurol
; 266(6): 1481-1489, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30904954
20.
Correction to: Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management.
J Neurol
; 2024 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38578500